Atria Investments Inc Has $9.98 Million Stock Holdings in McKesson Corporation $MCK

Atria Investments Inc boosted its position in shares of McKesson Corporation (NYSE:MCK) by 5.1% during the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 13,616 shares of the company’s stock after buying an additional 657 shares during the quarter. Atria Investments Inc’s holdings in McKesson were worth $9,978,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. MassMutual Private Wealth & Trust FSB lifted its stake in shares of McKesson by 1.6% in the 2nd quarter. MassMutual Private Wealth & Trust FSB now owns 863 shares of the company’s stock valued at $632,000 after purchasing an additional 14 shares during the period. Cardinal Point Capital Management ULC lifted its stake in shares of McKesson by 2.2% in the 2nd quarter. Cardinal Point Capital Management ULC now owns 645 shares of the company’s stock valued at $473,000 after purchasing an additional 14 shares during the period. SteelPeak Wealth LLC lifted its stake in shares of McKesson by 0.5% in the 1st quarter. SteelPeak Wealth LLC now owns 2,771 shares of the company’s stock valued at $1,867,000 after purchasing an additional 15 shares during the period. Cypress Wealth Services LLC lifted its stake in shares of McKesson by 3.7% in the 2nd quarter. Cypress Wealth Services LLC now owns 417 shares of the company’s stock valued at $305,000 after purchasing an additional 15 shares during the period. Finally, HBK Sorce Advisory LLC lifted its stake in shares of McKesson by 1.4% in the 2nd quarter. HBK Sorce Advisory LLC now owns 1,182 shares of the company’s stock valued at $866,000 after purchasing an additional 16 shares during the period. Institutional investors and hedge funds own 85.07% of the company’s stock.

Insider Activity

In other McKesson news, CEO Brian S. Tyler sold 11,930 shares of McKesson stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $705.63, for a total value of $8,418,165.90. Following the sale, the chief executive officer owned 4,012 shares of the company’s stock, valued at $2,830,987.56. This trade represents a 74.83% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CAO Napoleon B. Rutledge, Jr. sold 329 shares of McKesson stock in a transaction dated Friday, August 8th. The shares were sold at an average price of $663.67, for a total value of $218,347.43. Following the completion of the sale, the chief accounting officer directly owned 657 shares in the company, valued at $436,031.19. This represents a 33.37% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 24,189 shares of company stock worth $16,722,190 in the last three months. Company insiders own 0.08% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on MCK shares. TD Cowen increased their price target on McKesson from $830.00 to $864.00 and gave the company a “buy” rating in a research note on Wednesday, September 24th. Leerink Partners increased their price target on McKesson from $785.00 to $850.00 and gave the company an “outperform” rating in a research note on Wednesday, September 24th. Weiss Ratings reissued a “buy (b)” rating on shares of McKesson in a research note on Wednesday, October 8th. Wells Fargo & Company increased their price target on McKesson from $772.00 to $816.00 and gave the company an “equal weight” rating in a research note on Wednesday, September 24th. Finally, Mizuho raised their price objective on McKesson from $750.00 to $770.00 and gave the stock a “neutral” rating in a research note on Wednesday, September 24th. Two research analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $839.15.

McKesson Trading Up 2.3%

Shares of McKesson stock opened at $826.40 on Friday. The company has a market capitalization of $102.79 billion, a PE ratio of 32.95, a PEG ratio of 1.46 and a beta of 0.52. McKesson Corporation has a 12 month low of $498.32 and a 12 month high of $846.32. The stock’s fifty day simple moving average is $738.91 and its 200 day simple moving average is $717.98.

McKesson (NYSE:MCK) last issued its quarterly earnings data on Wednesday, August 6th. The company reported $8.26 EPS for the quarter, missing the consensus estimate of $8.33 by ($0.07). The business had revenue of $97.83 billion for the quarter, compared to analyst estimates of $95.93 billion. McKesson had a negative return on equity of 196.66% and a net margin of 0.84%.The business’s quarterly revenue was up 23.4% compared to the same quarter last year. During the same period in the previous year, the business posted $7.88 EPS. Analysts predict that McKesson Corporation will post 32.77 EPS for the current fiscal year.

McKesson Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, January 2nd. Shareholders of record on Monday, December 1st will be paid a $0.82 dividend. The ex-dividend date of this dividend is Monday, December 1st. This represents a $3.28 annualized dividend and a dividend yield of 0.4%. McKesson’s dividend payout ratio (DPR) is currently 13.08%.

McKesson Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.